Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshito Takeda

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Briefings in Bioinformatics|April 14, 2026
Subset binding enables detection of multimodal patient subgroup patterns and drug target discovery in idiopathic pulmonary fibrosisYayoi Natsume-Kitatani, Mari N Itoh, Yoshito Takeda, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2026
Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancerKinnosuke Matsumoto, Yuji Yamamoto, Takayuki Shiroyama, et al.
JCI Insight|October 5, 2018
Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patientsAkio Osa, Takeshi Uenami, Shohei Koyama, et al.
Scientific Reports|March 25, 2018
Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated agingYingji Jin, Yoshito Takeda, Yasushi Kondo, et al.
Respiratory Research|April 24, 2025
Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung diseaseTakatoshi Enomoto, Yoshito Takeda, Yuya Shirai, et al.
JCI Insight|December 21, 2018
Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cellsYuhei Kinehara, Izumi Nagatomo, Shohei Koyama, et al.
Nature Genetics|July 28, 2025
Deciphering state-dependent immune features from multi-layer omics data at single-cell resolutionRyuya Edahiro, Go Sato, Tatsuhiko Naito, et al.
Cancers|January 21, 2023
WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1Yusuke Oji, Naoki Kagawa, Hideyuki Arita, et al.
JCI Insight|June 10, 2024
SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosisTakatoshi Enomoto, Yuya Shirai, Yoshito Takeda, et al.
The Journal of Allergy and Clinical Immunology|March 29, 2024
Galectin-10 in serum extracellular vesicles reflects asthma pathophysiologyHanako Yoshimura, Yoshito Takeda, Yuya Shirai, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Briefings in Bioinformatics|April 14, 2026
Subset binding enables detection of multimodal patient subgroup patterns and drug target discovery in idiopathic pulmonary fibrosisYayoi Natsume-Kitatani, Mari N Itoh, Yoshito Takeda, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2026
Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancerKinnosuke Matsumoto, Yuji Yamamoto, Takayuki Shiroyama, et al.
JCI Insight|October 5, 2018
Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patientsAkio Osa, Takeshi Uenami, Shohei Koyama, et al.
Scientific Reports|March 25, 2018
Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated agingYingji Jin, Yoshito Takeda, Yasushi Kondo, et al.
Respiratory Research|April 24, 2025
Serum C-C motif chemokine ligand 17 as a predictive biomarker for the progression of non-idiopathic pulmonary fibrosis interstitial lung diseaseTakatoshi Enomoto, Yoshito Takeda, Yuya Shirai, et al.
JCI Insight|December 21, 2018
Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cellsYuhei Kinehara, Izumi Nagatomo, Shohei Koyama, et al.
Nature Genetics|July 28, 2025
Deciphering state-dependent immune features from multi-layer omics data at single-cell resolutionRyuya Edahiro, Go Sato, Tatsuhiko Naito, et al.
Cancers|January 21, 2023
WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1Yusuke Oji, Naoki Kagawa, Hideyuki Arita, et al.
JCI Insight|June 10, 2024
SFTPB in serum extracellular vesicles as a biomarker of progressive pulmonary fibrosisTakatoshi Enomoto, Yuya Shirai, Yoshito Takeda, et al.
The Journal of Allergy and Clinical Immunology|March 29, 2024
Galectin-10 in serum extracellular vesicles reflects asthma pathophysiologyHanako Yoshimura, Yoshito Takeda, Yuya Shirai, et al.
Pageof 15